USP & IPC in Final Discussion on Sharing Information on Chemical Reference Substances
USP officials informed that if things go as planned, IPC will be getting exclusive rights to get access to select data on some of the chemical reference substances from USP's database.
Indian Pharmacopoeia Commission (IPC) and United States Pharmacopoeia (USP) are in the final stages of their discussion to develop a collaborative agreement specifically for sharing information on chemical reference substances produced by USP.
USP officials informed that if things go as planned, IPC will be getting exclusive rights to get access to select data on some of the chemical reference substances from USP's database.
According to sources, as of now active dialogue is going on between the two standard setting body on finalising the reference substances. It is understood that as of now IPC have identified about four to five chemical substances and are in the process of identifying some more.
Related News
-
News CPhI North America Lookahead: Facilitating ‘meaningful conversations’ on needs and solutions
CPhI NA takes place as a SMART event this year, with online learning and networking from May 9-27 and an in-person event from May 17-19 in Philadelphia, PA. -
News Early development demand continues to boost prospects for smaller CDMOs: CPhI Worldwide panel
The increasing outsourcing trend among pharmaceutical companies represents a promising opportunity for CDMOs. This panel discussion at CPhI Worldwide touched upon some of the opportunities, hurdles, and trends ahead for the CDMO market -
News CPhI Worldwide is back, and this time it’s hybrid
A new in-person and online edition of CPhI Worldwide, transforming your event experience. -
News 5 Highlights from the Pharmapack Europe Content Programme
Pharmapack Europe is back! Join us online from 27 September as we kick off our two-week long content programme, a great precursor to the in-person event from 13-14 October at the Paris Expo Porte de Versailles. -
News Finding the right experts and collaborating at speed essential to COVID-19 vaccine rollout, says CPhI panel
CPhI Discover webinar examines the progress made so far in terms of vaccine distribution to the global population as well as anticipating future challenges -
News UPDATED: The CPhI Discover Blog
Bookmark this page for regular updates on the rich variety of content coming your way via CPhI Discover, pharma’s largest ever virtual gathering, over the course of our three-day agenda -
News COVID-19 has exacerbated contract manufacturing challenges but industry continues to respond well to crisis: experts
Coronavirus pandemic has exacerbated manufacturing capacity constraints, particularly in injectable dose and viral vector production, CPhI audience told -
News APIs, excipients and formulation: the bedrock of medical innovation
Our virtual CPHI Discover event (17th-28th May) is just around the corner, full to the brim with three main content tracks. Here, we explore the major trends in APIs, Ingredients & Formulation
Position your company at the heart of the global Pharma industry with a CPhI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPhI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance